Giant lysosomes as a chemotherapy resistance mechanism in hepatocellular carcinoma cells

Federico Colombo, Elena Trombetta, Paola Cetrangolo, Marco Maggioni, Paola Razini, Francesca De Santis, Yvan Torrente, Daniele Prati, Erminio Torresani, Laura Porretti

Research output: Contribution to journalArticle

Abstract

Despite continuous improvements in therapeutic protocols, cancer-related mortality is still one of the main problems facing public health. The main cause of treatment failure is multi-drug resistance (MDR: simultaneous insensitivity to different anticancer agents), the underlying molecular and biological mechanisms of which include the activity of ATP binding cassette (ABC) proteins and drug compartmentalisation in cell organelles. We investigated the expression of the main ABC proteins and the role of cytoplasmic vacuoles in the MDR of six hepatocellular carcinoma (HCC) cell lines, and confirmed the accumulation of the yellow anticancer drug sunitinib in giant (four lines) and small cytoplasmic vacuoles of lysosomal origin (two lines). ABC expression analyses showed that the main ABC protein harboured by all of the cell lines was PGP, whose expression was not limited to the cell membrane but was also found on lysosomes. MTT assays showed that the cell lines with giant lysosomes were more resistant to sorafenib treatment than those with small lysosomes (p

Original languageEnglish
Article numbere114787
JournalPLoS One
Volume9
Issue number12
DOIs
Publication statusPublished - Dec 10 2014

Fingerprint

Chemotherapy
lysosomes
hepatoma
Lysosomes
resistance mechanisms
drug therapy
Hepatocellular Carcinoma
Adenosine Triphosphate
antineoplastic agents
Cells
cell lines
Drug Therapy
Carrier Proteins
vacuoles
Vacuoles
Cell Line
proteins
multiple drug resistance
Pharmaceutical Preparations
cells

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Giant lysosomes as a chemotherapy resistance mechanism in hepatocellular carcinoma cells. / Colombo, Federico; Trombetta, Elena; Cetrangolo, Paola; Maggioni, Marco; Razini, Paola; De Santis, Francesca; Torrente, Yvan; Prati, Daniele; Torresani, Erminio; Porretti, Laura.

In: PLoS One, Vol. 9, No. 12, e114787, 10.12.2014.

Research output: Contribution to journalArticle

Colombo, Federico ; Trombetta, Elena ; Cetrangolo, Paola ; Maggioni, Marco ; Razini, Paola ; De Santis, Francesca ; Torrente, Yvan ; Prati, Daniele ; Torresani, Erminio ; Porretti, Laura. / Giant lysosomes as a chemotherapy resistance mechanism in hepatocellular carcinoma cells. In: PLoS One. 2014 ; Vol. 9, No. 12.
@article{ae175c133c2d453c8e81d58c5bfc050a,
title = "Giant lysosomes as a chemotherapy resistance mechanism in hepatocellular carcinoma cells",
abstract = "Despite continuous improvements in therapeutic protocols, cancer-related mortality is still one of the main problems facing public health. The main cause of treatment failure is multi-drug resistance (MDR: simultaneous insensitivity to different anticancer agents), the underlying molecular and biological mechanisms of which include the activity of ATP binding cassette (ABC) proteins and drug compartmentalisation in cell organelles. We investigated the expression of the main ABC proteins and the role of cytoplasmic vacuoles in the MDR of six hepatocellular carcinoma (HCC) cell lines, and confirmed the accumulation of the yellow anticancer drug sunitinib in giant (four lines) and small cytoplasmic vacuoles of lysosomal origin (two lines). ABC expression analyses showed that the main ABC protein harboured by all of the cell lines was PGP, whose expression was not limited to the cell membrane but was also found on lysosomes. MTT assays showed that the cell lines with giant lysosomes were more resistant to sorafenib treatment than those with small lysosomes (p",
author = "Federico Colombo and Elena Trombetta and Paola Cetrangolo and Marco Maggioni and Paola Razini and {De Santis}, Francesca and Yvan Torrente and Daniele Prati and Erminio Torresani and Laura Porretti",
year = "2014",
month = "12",
day = "10",
doi = "10.1371/journal.pone.0114787",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - Giant lysosomes as a chemotherapy resistance mechanism in hepatocellular carcinoma cells

AU - Colombo, Federico

AU - Trombetta, Elena

AU - Cetrangolo, Paola

AU - Maggioni, Marco

AU - Razini, Paola

AU - De Santis, Francesca

AU - Torrente, Yvan

AU - Prati, Daniele

AU - Torresani, Erminio

AU - Porretti, Laura

PY - 2014/12/10

Y1 - 2014/12/10

N2 - Despite continuous improvements in therapeutic protocols, cancer-related mortality is still one of the main problems facing public health. The main cause of treatment failure is multi-drug resistance (MDR: simultaneous insensitivity to different anticancer agents), the underlying molecular and biological mechanisms of which include the activity of ATP binding cassette (ABC) proteins and drug compartmentalisation in cell organelles. We investigated the expression of the main ABC proteins and the role of cytoplasmic vacuoles in the MDR of six hepatocellular carcinoma (HCC) cell lines, and confirmed the accumulation of the yellow anticancer drug sunitinib in giant (four lines) and small cytoplasmic vacuoles of lysosomal origin (two lines). ABC expression analyses showed that the main ABC protein harboured by all of the cell lines was PGP, whose expression was not limited to the cell membrane but was also found on lysosomes. MTT assays showed that the cell lines with giant lysosomes were more resistant to sorafenib treatment than those with small lysosomes (p

AB - Despite continuous improvements in therapeutic protocols, cancer-related mortality is still one of the main problems facing public health. The main cause of treatment failure is multi-drug resistance (MDR: simultaneous insensitivity to different anticancer agents), the underlying molecular and biological mechanisms of which include the activity of ATP binding cassette (ABC) proteins and drug compartmentalisation in cell organelles. We investigated the expression of the main ABC proteins and the role of cytoplasmic vacuoles in the MDR of six hepatocellular carcinoma (HCC) cell lines, and confirmed the accumulation of the yellow anticancer drug sunitinib in giant (four lines) and small cytoplasmic vacuoles of lysosomal origin (two lines). ABC expression analyses showed that the main ABC protein harboured by all of the cell lines was PGP, whose expression was not limited to the cell membrane but was also found on lysosomes. MTT assays showed that the cell lines with giant lysosomes were more resistant to sorafenib treatment than those with small lysosomes (p

UR - http://www.scopus.com/inward/record.url?scp=84918507737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918507737&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0114787

DO - 10.1371/journal.pone.0114787

M3 - Article

AN - SCOPUS:84918507737

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e114787

ER -